BAK Stock Recent News

BBCP, BAK and KMX made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on January 23, 2025.

BRLT, GTLB, BBCP, BAK and KMX have been added to the Zacks Rank #1 (Strong Buy) List on January 23, 2025.

Here is how Braskem (BAK) and Kinder Morgan (KMI) have performed compared to their sector so far this year.

Why Braskem's Stock Breakout Signals A Strong Buy Opportunity

Braskem (BAK) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

Braskem S.A.'s strategies to lower emissions and develop sustainable chemicals are likely to attract significant interest from ESG investors, enhancing stock demand. The company's asset optimization initiatives and transactions, such as the 2024 asset sale to Solví and GRI, are expected to positively impact financial statements. Investments in research and development, including a new Renewable Innovation Center in Massachusetts, are anticipated to drive innovation and free cash flow margin growth.

The heavy selling pressure might have exhausted for Braskem (BAK) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

PHILADELPHIA--(BUSINESS WIRE)-- #braskem--Braskem (B3: BRKM3, BRKM5, and BRKM6; NYSE: BAK; LATIBEX: XBRK) the largest polyolefins producer in the Americas, as well as a global market leader and pioneer producer of biopolymers on an industrial scale, and WEAV3D Inc., an advanced manufacturing and materials startup, today announced Braskem's and WEAV3D Inc.'s thermoplastic composite lattice technology, in partnership with the Clemson Composites Center at Clemson University, was selected Most Innovative Part.

PHILADELPHIA & HOUSTON--(BUSINESS WIRE)-- #braskem--Braskem (B3: BRKM3, BRKM5, and BRKM6; NYSE: BAK; LATIBEX: XBRK), the Americas' leading polyolefins producer and a global pioneer in biopolymers, today proudly announces that the company has been selected by the U.S. Department of Energy's Office of Manufacturing and Energy Supply Chains to negotiate terms of a $50 million award under the Bipartisan Infrastructure Law. This landmark funding would expand Braskem's ultra-high molecular weight polyethylene (.

I recommend buying Braskem shares post-2Q24 results, which showed operational improvement despite missing market expectations and ongoing financial challenges. BAK's revenue remained stable at $3.65 billion, with excellent cost control leading to a 9% recurring EBITDA margin. Valuation is attractive with a potential 33.8% appreciation, trading at 6.5x EV/EBITDA against an industry average of 8.7x.